Tessari Eben bought KNSA

April 1, 2026 · Form 4 insider transaction

Tessari Eben bought 33,200 shares of Kiniksa Pharmaceuticals International, plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
33,200
Price
$0.00
Total value
N/A
RoleOfficer
SecurityShare Option
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after33,200
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April1, 2026.

View the original Form 4 on SEC EDGAR